Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
86,279,161
-
Share change
-
+2,498,520
-
Total reported value
-
$5,708,002,798
-
Put/Call ratio
-
178%
-
Price per share
-
$66.41
-
Number of holders
-
360
-
Value change
-
+$184,430,573
-
Number of buys
-
213
-
Number of sells
-
134
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q2 2019
As of 30 Jun 2019 Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) had 360 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 86,279,161 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, ALLIANCEBERNSTEIN L.P., WADDELL & REED FINANCIAL INC, BANK OF AMERICA CORP /DE/, ZEVENBERGEN CAPITAL INVESTMENTS LLC, and RIVERBRIDGE PARTNERS LLC.
This table shows 360 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.